Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 3,54 Md
0,58 %0,66 %17.51x2.02x3.84x10.32x11.38x 68,8 Md
0,58 %0,59 %27.36x4.11x5.63x16.53x20.89x 55,21 Md
-.--%-.--%35.27x7.08x11.95x22.64x26.61x 43,46 Md
3,32 %3,4 %-46.27x2.52x3.25x9.6x11.21x 41,18 Md
-.--%-.--%-9.21x5.42x13.41x-8.22x-7.77x 31,65 Md
-.--%-.--%31.34x1.61x3.56x11.02x12.92x 30,37 Md
-.--%-.--%17.13x3.43x3.29x9.96x9.78x 23,58 Md
-.--%0,05 %56.27x5.53x6.08x42.2x39.03x 19,33 Md
-.--%-.--%26.8x3.75x5.49x14.74x20.37x 17,16 Md
-.--%-.--%-35.54x-6.21x16.63x-50.5x-52.95x 15,27 Md
-.--%-.--%-125.69x13228.81x12.92x-114.56x-127.57x 12,85 Md
0,15 %0,16 %61.75x25.18x37.5x53.04x54.7x 11,93 Md
-.--%-.--%17.13x - 3.64x13.33x15.98x 11,66 Md
-.--%-.--%47.81x - - - - 10,87 Md
2,82 %3,26 %11.89x1.04x1.81x7.29x9.77x 6,24 Md
1,55 %1,72 %14.54x1.34x2.59x6.7x8.11x 5,83 Md
0,37 %0,43 %28.21x - 7.57x20.1x24x 5,74 Md
Moyenne 0,55 % 0,6 % 10,37x 948,97x 8,70x 4,01x 4,78x 23,04 Md
Moyenne pondérée par Capi. 0,58 % 0,62 % 11,12x 447,93x 7,57x 7,80x 9,17x
Biopharmacies
🔇